Glycemia optimization treatment (GOT): Glycemic control and rate of severe hypoglycemia for five different dosing algorithms of insulin glargine (GLAR) in patients with type 2 diabetes mellitus (T2DM)

被引：0

|

作者：

Tanenberg, Robert J.

Zisman, Ariel

Stewart, John

机构：

来源：

DIABETES | 2006年 / 55卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A135 / A135

页数：1

相关论文

共 50 条

[1] Glycaemia optimization treatment (GOT): Glycaemic control and rate of severe hypoglycaemia for 5 different dosing algorithms of insulin glargine (GLAR) in patients with type 2 diabetes mellitus (T2DM)
Tanenberg, R. J.
Zisman, A.
Stewart, J. A.
[J]. DIABETOLOGIA, 2006, 49 : 601 - 602
[2] Glycemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C study
Halter, Jeffrey B.
Kennedy, Laurence
Herman, William H.
Miller, Michael E.
[J]. DIABETES, 2006, 55 : A114 - A115
[3] Influence of Gender on Glycemic Control and Hypoglycemia in T2DM Patients Initiating Insulin Glargine
Kautzky-Willer, Alexandra
Traylor, Louise
Landgraf, Wolfgang
Charbonnel, Bernard
[J]. DIABETES, 2015, 64 : A257 - A257
[4] Physician beliefs in efficacy of insulin glargine (GLAR) are associated with glucose control in type 2 diabetes (T2DM)
Herman, W.
Zhang, Q.
Kennedy, L.
[J]. DIABETOLOGIA, 2006, 49 : 527 - 528
[5] Glycaemic control and safety of insulin glargine (GLAR) in elderly patients with type 2 diabetes mellitus (T2DM): The GOAL A1C study
Halter, J.
Kennedy, L.
Miller, M.
Herman, W.
[J]. DIABETOLOGIA, 2006, 49 : 602 - 603
[6] Age, BMI, and Diabetes Duration: Effect on Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes (T2DM)
Twigg, Stephen M.
Escalada, Javier
Grisoni, Marie-Lise
Stella, Peter
Merino-Trigo, Ana
Lavalle Gonzalez, Fernando J.
Cariou, Bertrand
Meneghini, Luigi F.
[J]. DIABETES, 2015, 64 : A260 - A260
[7] DELAYED TREATMENT MODIFICATIONS FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) WITH VERY POOR GLYCEMIC CONTROL
Schwab, P.
Saundankar, V
Bouchard, J. R.
Moretz, C.
Baltz, J.
[J]. VALUE IN HEALTH, 2014, 17 (03) : A264 - A264
[8] Glycemic control achieved with insulin glargine (GLAR) as "Add-on" therapy in type 2 diabetes mellitus (T2DM) is unaffected by age, race, diabetes duration or BMI: The GOAL A1C study
Kennedy, L
Herman, WH
Harris, A
Strange, P
[J]. DIABETES, 2005, 54 : A141 - A141
[9] Effects of Insulin Glargine vs Thiazolidinediones on Glycemic and Lipid Variables in Type 2 Diabetes Mellitus (T2DM): The Impact of Obesity
Meneghini, Luigi F.
Rosenberg, Noah
Hollander, Priscilla
Rosenstock, Julio
Riddle, Matthew C.
Nesto, Richard W.
Dandona, Paresh
[J]. DIABETES, 2009, 58 : A523 - A523
[10] 2-year glycemic control following initiation of insulin glargine versus NPH insulin in individuals with type 2 diabetes (T2DM)
J, Leahy
Dain, M. P.
Rhoads, G. G.
Kennedy, L.
[J]. VALUE IN HEALTH, 2007, 10 (06) : A257 - A258

← 1 2 3 4 5 →